Australia's most trusted
source of pharma news
Thursday, 13 November 2025
Posted 13 November 2025 PM
Eli Lilly’s Dave Ricks has been named CEO of the Year by the Chief Executive Group.
“Under Ricks’ leadership, Lilly has transformed from a US$22 billion company facing losses into a global powerhouse projected to surpass US$60 billion in revenue this year - while staying true to its core values of scientific excellence and patient-centered care,” Chief Executive Group said.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.